ZetrOZ systems showcased at the 2022 PHATS/SPHEM Annual Conference

At a recent conference of professional hockey coaches, ZetrOZ Systems, a leading innovator and inventor of Sustained Acoustic Medicine (sam®) for healing soft tissue injuries, presented study results indicating that the medical device is very effective in treating kinds of injuries of hockey players. frequently experience.

Dr. George Lewis

Dr. George Lewis

TRUMBULL, Conn., Aug. 17, 2022 (GLOBE NEWSWIRE) — ZetrOZ Founder and CEO George Lewis, Ph.D., spoke at the 2022 PHATS (Professional Hockey Athletic Trainers Society) SPHEM (Society of Professional Hockey Equipment Managers) Annual Conference, at the JW Marriott Marco Island Beach Resort in late June.

Speaking to over 100 professional athletic trainers and equipment managers, Lewis spoke about the use of sam® for common soft tissue injuries, the clinical research conducted on sam®, and the actual results of actual results.

Research indicates that hockey players are particularly at risk for lower back injuries, due to the flexed (forward) posture of skating and frequent hyperextension (backward) stress; soft tissue injuries, including groin and hip flexor strains, due to the mechanics of the skating stride; and injuries to the medial collateral ligament of the knee due to the position of the leg during skating.

Lewis’ lecture presented a recent clinical study examining the effectiveness of sam® on soft tissue injury in patients who have failed to respond to traditional RICE therapies (rest, ice, compression, elevation). The results showed that:

  • 95% of patients were able to apply and perform the sam® treatment;

  • 93% of patients think that sam® is very easy to use;

  • 87% of participants experienced improved function and quality of life;

  • 55% were able to resume activity immediately after treatment;

  • and patients saw a 20% reduction in blood lactate and an improvement in joint function of 27% to 87%.

“We find that it takes more than RICE to get back on the ice. sam® is a non-invasive, non-narcotic pain alternative and the results speak for themselves,” Lewis said. “Sustained Acoustic Medicine is well suited for the type of soft tissue and musculoskeletal injuries commonly suffered by hockey players.”

“Coaches and managers were particularly sensitive to the ease of use of the device and how quickly athletes could return to normal activity after treatment,” Lewis said.

The ZetrOZ team also met with members of the Connecticut Whale, a professional women’s ice hockey team based in Danbury, Connecticut, and sponsored by ZetrOZ, to discuss the latest findings and research on sam® for musculoskeletal injuries.

ZetrOZ Systems is a platinum sponsor of the 2022 PHATS/SPHEM conference. PHATS/SPHEM has over 600 members, representing over 100 professional, NCAA and Canadian Junior League teams across North America and Europe .

To learn more about ZetrOZ Systems and its innovative healthcare solutions, visit www.zetroz.com.

About ZetrOZ Systems

ZetrOZ Systems is an FDA cGMP and ISO 13585 medical technology company headquartered in the Southern Coastal region of Connecticut. The organization also has manufacturing facilities across the United States. ZetrOZ Systems produces UltrOZ®, sam®Sport and sam®Pro 2.0 to provide safe and effective treatment options for common conditions such as arthritis. Learn more about www.zetroz.com and samrecover.com.

Media Contact

Kayar nozzle
[email protected]

Related Images

Image 1: Dr. George Lewis

Dr. George Lewis presents clinical training in sustained acoustic medicine for healing professional hockey players with overuse injuries.

Image 2: ZetrOZ Systems – PHATS Conference

Dr. George Lewis presents clinical training in sustained acoustic medicine for healing professional hockey players with overuse injuries.

This content was published via the newswire.com press release distribution service.


Previous How Harrogate objections halted plans for a Leeds conference venue - for now
Next The former Black Horse pub music venue in Birmingham is up for sale